Vagus nerve stimulation for treatment-resistant depression;La stimolazione del nervo vago nel trattamento della depressione resistente

Italian Journal of Psychopathology

Volumn 15, Issue 2, 2009, Pages 151-162

  Maina, Giuseppe ^a   Albert, U ^a   Bertetto, N ^a   Pessina, E ^a   Vitalucci, A ^a   Bogetto, F ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Treatment resistant depression (TRD); Vagus nerve stimulation (VNS)

Indexed keywords

ARTICLE; CLINICAL TRIAL; DEPRESSION; DEVICE THERAPY; HUMAN; IMPLANTATION; LONG TERM CARE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VAGUS NERVE STIMULATION;

EID: 70349575240     PISSN: 15921107     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Depression physician's manual. Houston, TX: Cyberonics, Inc. 2005.
2. Dodrill CB. Cognitive and quality of life changes with VNS therapy: results from a randomized controlled trial. In: Current results and perspectives on vagus nerve stimulation for the treatment of epilepsy. Houston, TX: Cyberonics 1997.
3. Harden CL, Lazar LM, Pick LH, Nikolov B, Goldstein MA, Carson D, et al. A beneficial effect on mood in partial epilepsy patients treated with gabapentin. Epilepsia 1999;40:1129-1134 (Pubitemid 29372629)
4. Harden CL, Pulver MC, Ravdin LD, Nikolov B, Halper JP, Labar DR. A pilot study of mood in epilepsy patients treated with vagus nerve stimulation. Epilepsy Behav 2000;1:93-99.
5. Elger G, Hoppe C, Falkai P, Rush AJ, Elger CE. Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Res 2000;42:203-210 (Pubitemid 30829566)
6. Murray CJ, Lopez AJ. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349:1498-1504
7. Nemeroff CB. Prevalence and management of treatment-resistant depression. J Clin Psychiatry 2007;68:17-25.
8. Dunner DL, Rush AJ, Russell JM, Burke M, Woodard S, Wingard P, et al. Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression. J Clin Psichiatry 2006;67:688-695 (Pubitemid 43946174)
9. Office of Device Evaluation. VNS therapy System p970003s050. Avaible at: http://www.fda.gov/cdrh/pdf/p97003s050.html 2006. Accessed December 18.
10. Henry TR. Therapeutic mechanism of vagus nerve stimulation. Neurology 2002;59:3-14.
11. Nemeroff CB, Mayberg HS, Krahl SE, McNamara J, Frazer A, Henry TR, et al. VNS therapy in treatmentresistant depression: clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology 2006;31:1345-1355 (Pubitemid 43910430)
12. Berthoud H-R, Neuhuber WL. Functional and chemical anatomy of the afferent vagal system. Auton Neurosci 2000;85:1-17.
13. George MS, Sackeim HA, Marangell LB, Husain MM, Nahas Z, Lisanby SH, et al. Vagus nerve stimulation. A potential therapy for resistant depression? Psychiatr Clin North Am 2000;23:757-783
14. '4 George MS, Sackeim HA, Rush AJ, Marangell LB, Nahas Z, Husain MM, et al. Vagus nerve stimulation: a new tool for brain research and therapy. Biol Psychiatr 2000;47:287-295 (Pubitemid 30109241)
15. Lenox RH, Frazer A. Mechanism of action of antidepressants and mood stabilizers. In: Davis KL, Charney D, Coyle JT, Nemeroff C, editors. Neuropsychopharmacology: the fifty generation of progress. Philadelphia: Lippincott Williams & Wilkins 2002, pp. 1139-1163
16. th Annual Scientific Convention of the Society of Biological Psychiatry, San Francisco, CA, May 15-17, 2003.
17. Krahl SE, Senanayake SS, Pekary AE, Sattin A. Vagus nerve stimulation (VNS) is effective in a rat model of antidepressant action. J Psychiatr Res 2004;38:237-240 (Pubitemid 38299160)
18. Debonnell G, Dorr AE. Effect of vagus nerve stimulation (VNS) on dorsal raphe serotoninergic neurons: an electrophysiological study in the rat. Poster presented at the Society for Neuroscience Annual Meeting, San Diego, CA, October 23-27, 2004.
19. Chae JH, Nahas Z, Lomarev M, Denslow S, Lorberbaum JP, Bohning DE, et al. A review of functional neuroimaging studies of vagus nerve stimulation (VNS). J Psychiatr Res 2003;37:443-455
20. th edn. Text revision (DSM-IV-TR). Washington, DC, 2000.
21. Rush AJ, George MS, Sackeim HA, Marangell LB, Husain MM, Giller C, et al. Vagus nerve stimulation (VNS) for treatment-resistant depression: a multicenter study. Biol Psichiatr 2000;47:276-286 (Pubitemid 30109240)
22. Sackeim HA, Rush AJ, George MS, Marangell LB, Husain MM, Nahas Z, et al. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacol 2001;25:713-728 (Pubitemid 32995954)
23. George R, Salinsky M, Kuzniecky R, Rosenfeld W, Bergen D, Tarver WB, et al. Vagus nerve stimulation for treatment of partial seizures: 3. Long-term follow-up on first 67 patients exiting a controlled study (First International Vagus Nerve Stimulation Study Group). Epilepsia 1994;35:637-643
24. Salinsky MC, Uthman BM, Ristanovic RK, Wernicke JF, Tarver WB. Vagus nerve stimulation for the treatment of medically intractable seizures. Results of a 1-year open-extension trial. Vagus Nerve Stimulation Study Group. Arch Neurol 1996;53:1176-1180
25. Morris GL, Mueller WM; The Vagus Nerve Stimulation Study Group. Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. Neurology 1999;53:1731-1735
26. DeGiorgio CM, Schachter SC, Handforth A, Salinsky M, Thompson J, Uthman B, et al. Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsia 2000;41:1195-1200
27. Marangell LB, Rush AJ, George MS, Sackeim HA, Johnson CR, Husain MM, et al. Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. Biol Psych 2002;51:280-287
28. Nahas Z, Marangell LB, Husain MM, Rush AJ, Sackeim HA, Lisanby SH, et al. Two year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psichiatry 2005;66:1097-1104
29. Rush AJ, Marangell LB, Sackeim HA, George MS, Brannan SK, Davis SM, et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled, acute phase trial. Biol Psichiatr 2005;58;347-354
30. Rush AJ, Sackeim HA, Marangell LB, George MS, Brannan SK, Davis SM, et al. Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatr 2005;58:355-363 (Pubitemid 41219703)
31. George MS, Rush AJ, Marangell LB, Sackeim HA, Brannan SK, Davis SM, et al. A one year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatr 2005;58:364-373
32. Schlaepfer TE, Frick C, Zobel A, Maier W, Heuser I, Bajbouj M, et al. Vagus nerve stimulation for depression: efficacy and safety in a European study. Psychol Med 2008;38:651-661
33. Montgomery SA, Rasmussen JG, Tanghoj P. A 24-week study of 20 mg citalopram, 40 mg citalopram, and placebo in the prevention of relapse of major depression. Int Clin Psychopharmacol 1993;8:181-188 (Pubitemid 23294925)
34. Dago P, Quitkin F. Role of the placebo response in the treatment of depressive disorders. CNS Drugs 1995;4:335-340
35. Schacter SC. Vagus nerve stimulation therapy summary: five years after FDA approval. Neurology 2002;59:15-20.
36. DeGiorgio C, Heck C, Bunch S, Britton J, Green P, Lancman M, et al. Vagus nerve stimulation for epilepsy: randomized comparison of three stimulation paradigms. Neurology 2005;65:317-319 (Pubitemid 41022385)
37. Labiner DM, Ahern JL. Vagus nerve stimulation therapy in depression and epilepsy: therapeutic parameter settings. Acta Neurol Scand 2007;115:23-33.
38. Heck C, Helmers SL, DeGiorgio CM. Vagus nerve stimulation therapy, epilepsy and device parameters: scientific basis and recommendations for use. Neurology 2002;59:31-37
39. Labiner D, Schwirtz D, Ahern G, MacDonald J, Weinand M. Shorter pulse width of vagus nerve stimulation is as effective in reducing seizure frequency as standard stimulation and is better tolerated. Epilepsia 1999;40:141.
40. Liporace J, Hucko D, Morrow R, Barolat G, Nei M, Schnur J, et al. Vagal nerve stimulation: adjustements to reduce painful side effects. Neurology 2001;57:885-886 (Pubitemid 32845512)
41. Agnew WF, McCreery DB. Considerations for safety with chronically implanted nerve electrodes. Epilepsia 1990;31:27-32.
42. Daban C, Martinez-Aran A, Cruz N, Vieta E. Safety and efficacy of Vagus Nerve Stimulation in treatment-resistant depression. A systematic review. J Affect Disord 2008;110:1-15.
43. Marangell LB, Suppes T, Zboyan HA, Prashad SJ, Fischer G, Snow D, et al. A 1-year pilot study of vagus nerve stimulation in treatment-resistant rapid-cycling bipolar disorder. J Clin Psychiatry 2008;69:183-189